Decline depth
-75.3%
From rolling 252-day high of $33.68, 134d ago.
Past the 40% Red List threshold.
-75.3%
from rolling 252-day high of $33.68 set 2026-01-14 · 134d ago
Current
$8.32
Decline depth
-75.3%
Decline σ
4.9σ
TFC
4/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since tracking began
$UPB has been tracked since 2026-03-01. It was down 77.1% from its 52-week high then — now down -75.3%.
That's 4.8 percentage points deeper than the day it joined.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
UPB qualifies for the Red List on decline depth.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 4/5 Amber threshold.
Decline sigma
4.9σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.14% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about UPB.
UPB qualifies for the Red List on decline depth — down -75.3% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
Cross-confirmation: also showing 4/5 bearish time frames.
Cross-confirmation: decline sigma also reads 4.9σ over 20 bars.
Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (green), weekly 1 (red), monthly 2D (red).
52-week range
52W low $5.14
11.1% of range
52W high $33.68
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
88
Red List
47
Amber
59
Watch
-35.8%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to UPB
Red List
KRRO
Korro Bio, Inc.
Red List
OPRX
OptimizeRx Corporation
Red List
DOCS
Doximity, Inc.
Red ListRecovering
PHR
Phreesia, Inc.
Red List
WGS
GeneDx Holdings Corp.
Red ListRecovering
MLTX
MoonLake Immunotherapeutics
Questions about UPB
What people ask.
Why is UPB on Broken Stocks?
UPB qualifies for the Red List on decline depth. It is down -75.3% from its rolling 252-day high of $33.68, set on 2026-01-14 — 134d ago.
Is UPB a falling knife?
Not by the strict technical definition. UPB is down -75.3% from its 52-week high, but that high was set 134d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. UPB is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is UPB a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is UPB trading inside its 52-week range?
At $8.32, UPB sits 11.1% of the way from its 52-week low ($5.14) to its 52-week high ($33.68). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has UPB been declining?
The current 75.3% decline accrued over 134d, which annualizes to roughly -205.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does UPB compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — UPB's decline is deeper than the sector median.